Together, these results suggest that visfatin activates JAK2-STAT3 signaling in CAFs in a ROS dependent manner and oxidative stress and JAK2-STAT3 signaling are required for the pro-metastatic effect of visfatin-stimulated CAFs in CRC. The gene discussed is STAT3; the disease is colorectal carcinoma.